Georgia State will be responsible for the learning analytics portion of the project, a collaborative effort by Georgia universities and other partners.
Compounds targeting two key enzymes are potent inhibitors of SARS-CoV-2, the virus that causes COVID-19, according to a study led by the Institute for Biomedical Sciences at Georgia State.
Robert Hatcher's (B.A. ’17, MBA ’20) company, Aurign, uses data and technology to make sure musicians and producers get the royalties they've rightfully earned.
Georgia State Alumni Association 40 Under 40 honoree and rocket scientist Kavya Manyapu has been tapped to work with NASA’s Artemis program.
An award-winning play about a computer programmer gets turned into an interactive live experience with the help of Georgia State.
An influenza vaccine that is made of nanoparticles and administered through the nose enhances the body’s immune response to influenza virus infection and offers broad protection against different viral strains, according to researchers in the Institute for Biomedical Sciences at Georgia State University.
Camila Gomez, who helped her own mother through her cancer treatments, aspires to be a role model for minorities in STEM fields.
ARCTIC is aimed at investigators not traditionally served by high-performance computing, such as psychologists or public policy researchers.
The researchers will use the approaches they develop to identify new clues about how mental illness presents in the brain.
Gem Johnson has continued her cardiovascular research during the pandemic, even though she hasn’t been able to enter the lab.
